Sulfisoxazole is a broad-spectrum, short-acting sulfonamide antimicrobial agent that serves as a synthetic analog of para-aminobenzoic acid to inhibit bacterial folate synthesis. Primarily utilized in… Read more
Sulfisoxazole is a broad-spectrum, short-acting sulfonamide antimicrobial agent that serves as a synthetic analog of para-aminobenzoic acid to inhibit bacterial folate synthesis. Primarily utilized in the treatment of urinary tract infections and various other bacterial infections, this medication requires rigorous quality assessment. This category provides essential reference standards for sulfisoxazole, its acetyl derivative, and the closely related compound sulfafurazole. Laboratories rely on these high-quality materials, including pharmaceutical impurities, metabolites, and stable isotope labelled compounds, for accurate impurity profiling and method validation. These analytical standards are critical for supporting reliable quality control processes throughout pharmaceutical development and manufacturing, ensuring compliance with established pharmacopeial requirements for potency and purity in antimicrobial analysis.